Related Experiment Video
Updated: Apr 27, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Rapidly progressive glomerulonephritis in tuberculosis
Rajesh Waikhom1, Dipankar Sarkar, Mahesh Bennikal
1Department of Nephrology, Jawaharlal Nehru Institute of Medical Sciences, Porompat Imphal, India.
Tuberculosis can affect the kidneys, but glomerular involvement is rare. This case shows successful treatment of miliary tuberculosis with immune complex nephritis using anti-tuberculous therapy alone, avoiding immunosuppression.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Renal tuberculosis is typically due to lympho-hematogenous spread.
- Glomerular involvement in renal tuberculosis is uncommon.
- Crescentic nephritis in tuberculosis presents a therapeutic challenge due to immunosuppression risks.
Observation:
- A patient presented with miliary tuberculosis and advanced renal injury requiring renal replacement therapy.
- Diagnosis was confirmed by positive sputum acid-fast bacilli (AFB), caseating granulomas in lymph nodes, and positive urinary mycobacterial PCR.
- The patient had immune complex crescentic nephritis.
Findings:
- Complete recovery of renal function was achieved with anti-tuberculous therapy.
- Immunosuppressive therapy was not required for managing the nephritis.
- This suggests a potential for non-immunosuppressive treatment in select cases.
Implications:
- This case highlights that renal tuberculosis with immune complex crescentic nephritis can be managed effectively with anti-tuberculous therapy alone.
- It offers a less risky therapeutic approach, avoiding immunosuppression in patients with active tuberculosis.
- Further research may explore the role of anti-tuberculous therapy as a primary treatment for tuberculous nephritis.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Pyelonephritis I: Introduction
